Compare Teucrium Corn Fund (CORN) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teucrium Corn Fund vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Teucrium Corn Fund trades at $18.99 (market cap $122.67M), while Halozyme Therapeutics Inc. Common Stock trades at $109.67 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 102.6× Teucrium Corn Fund's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Teucrium Corn Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Teucrium Corn Fund for 26 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| CORN | HALO | |
|---|---|---|
Market Cap | $122.67M | $12.58B |
Volume | 103,450 | 2,179,278 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $20.29 | $115.22 |
52-Week Low | $16.46 | $61.63 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | — | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Teucrium Corn Fund
CORN is a commodity ETF that provides exposure to the price of corn futures. It uses a laddered investment strategy across multiple benchmark contracts to help minimize the impact of contango and roll costs in the agricultural market.
Read more on CORN →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
